Skip to main content

Scientists Find New Way to Slow Deadly Brain Cancer

Published on June 22, 2026, 4:18 p.m.
Scientists Find New Way to Slow Deadly Brain Cancer

Topic: Biology

Researchers in Canada discovered that some brain cells help glioblastoma grow. They found an existing drug that could slow down the cancer's growth.

Scientists have long known that glioblastoma, a type of brain cancer, relies on networks of interacting cells to grow. A team of researchers at McMaster University and The Hospital for Sick Children (SickKids) in Canada has identified a new way to slow down this process. They found that some brain cells, called oligodendrocytes, can actually help glioblastoma grow by sending signals to the cancer cells.

The study revealed that when these signals were blocked in laboratory models, tumor growth slowed significantly. This finding highlights a potential treatment opportunity for patients with glioblastoma, who currently have very limited options.

Glioblastoma is an aggressive and incurable type of brain cancer, with survival often measured in months. The researchers found that a drug already used to treat HIV might be able to interfere with this process, offering a new option for patients.

Why It Matters

This discovery could lead to new treatment options for Indian students' families who are affected by glioblastoma. It also shows how important it is to continue researching and understanding the biology of cancer.

Key Facts

  • Glioblastoma is an aggressive and incurable type of brain cancer
  • Researchers found that oligodendrocytes can help glioblastoma grow by sending signals to the cancer cells
  • Blocking these signals in laboratory models slowed down tumor growth significantly
  • A drug already used to treat HIV might be able to interfere with this process and slow down glioblastoma growth
  • Glioblastoma has a poor outlook, with survival often measured in months

Key Terms

Oligodendrocytes
A type of brain cell that can help glioblastoma grow

Implications

This discovery could lead to new treatment options for Indian students' families who are affected by glioblastoma. It also shows how important it is to continue researching and understanding the biology of cancer.


Source: https://www.sciencedaily.com/releases/2026/04/260405003933.htm

Journal Reference:

  1. Nicholas Mikolajewicz, Kui Zhai, Anish Puri, Petar Miletic, Nazanin Tatari, Jiarun Wei, Neil Savage, Zhi Huang, Qian Huang, Seon Yong Lee, Mahta Jan-Ahmadnejad, Roseanne Nguyen, David Chen, Tiegan Korman, Daniel Mobilio, Maxwell Topley, Jack Qinyu Lu, Matthew R. Voisin, Zsolt Zador, Shawn C. Chafe, Chitra Venugopal, Kevin R. Brown, Gelareh Zadeh, Hong Han, Julien Muffat, Shideng Bao, Sheila K. Singh, Jason Moffat. Reactive oligodendrocytes promote glioblastoma progression through CCL5/CCR5-mediated glioma stem cell maintenance. Neuron, 2026; 114 (2): 237 DOI: 10.1016/j.neuron.2025.12.012

Leave a Comment

Name
Email
Body
... ...

Get Exclusive Insights

with Every Issue

JoinShalyamNewsletter

Stay ahead in education, research, and innovation—straight to your inbox.